Cauvin A, Robberecht P, De Neef P, Gourlet P, Vandermeers A, Vandermeers-Piret M C, Christophe J
Department of Biochemistry and Nutrition, Medical School, Université Libre de Bruxelles, Belgium.
Regul Pept. 1991 Aug 13;35(2):161-73. doi: 10.1016/0167-0115(91)90478-y.
A high density (in the pmol/mg protein range) of specific functional receptors for PACAP (pituitary adenylate cyclase activating polypeptide) was observed in membranes from rat brain cortex, olfactory bulb, hypothalamus, hippocampus, striatum, cerebellum, pons and cervico-dorsal spinal cord, using [125I]PACAP-27 (PACAP 1-27). The tracer bound rapidly, specifically and reversibly. Competition binding curves were compatible with the coexistence, in the eight central nervous areas explored, of high and low affinity binding sites for PACAP-27 (Kd of 0.2 nM and 3.0 nM, respectively), and of only one class of binding sites for PACAP-38 (PACAP (1-38), Kd 0.2-0.9 nM). VIP inhibited only partially the binding of [125I]PACAP-27, and PHI, GRF(1-29)NH2 and secretin were ineffective at 1 microM. Chemical [125I]PACAP-27 cross-linking revealed a single specific 64 kDa protein species. In rat brain cortical membranes, saturation and competition experiments, using [125I]PACAP-38 as radioligand, indicated the presence of both high (Kd 0.13 nM) and low (Kd 8-10 nM) affinity binding sites for PACAP-38 and of low affinity (Kd 30 nM) binding sites for PACAP-27. These data taken collectively suggest the coexistence of PACAP-A receptors with a slight preference for PACAP-27 over PACAP-38 and of PACAP-B receptors that recognize PACAP-38 with a high affinity and PACAP-27 with low affinity. Both PACAP-27 and PACAP-38 stimulated adenylate cyclase with similar potency and efficacy. VIP was markedly less potent in this respect and also less efficient, except on cerebellar membranes.
利用[125I]PACAP - 27(垂体腺苷酸环化酶激活多肽1 - 27),在大鼠大脑皮层、嗅球、下丘脑、海马体、纹状体、小脑、脑桥和颈背脊髓的膜中观察到PACAP(垂体腺苷酸环化酶激活多肽)特异性功能受体的高密度(在皮摩尔/毫克蛋白质范围内)。示踪剂快速、特异性且可逆地结合。竞争结合曲线与在八个探索的中枢神经区域中同时存在对PACAP - 27的高亲和力和低亲和力结合位点(Kd分别为0.2 nM和3.0 nM)以及仅一类对PACAP - 38(垂体腺苷酸环化酶激活多肽(1 - 38),Kd 0.2 - 0.9 nM)的结合位点相一致。血管活性肠肽(VIP)仅部分抑制[125I]PACAP - 27的结合,而肽组氨酸异亮氨酸(PHI)、生长激素释放因子(GRF(1 - 29)NH2)和促胰液素在1 microM时无效。化学[125I]PACAP - 27交联显示出一种单一的特异性64 kDa蛋白种类。在大鼠大脑皮层膜中,以[125I]PACAP - 38作为放射性配体进行饱和和竞争实验,表明存在对PACAP - 38的高亲和力(Kd 0.13 nM)和低亲和力(Kd 8 - 10 nM)结合位点以及对PACAP - 27的低亲和力(Kd 30 nM)结合位点。综合这些数据表明,PACAP - A受体共存,对PACAP - 27的偏好略高于PACAP - 38,以及PACAP - B受体,其对PACAP - 38具有高亲和力,对PACAP - 27具有低亲和力。PACAP - 27和PACAP - 38刺激腺苷酸环化酶的效力和效能相似。在这方面,VIP的效力明显较低,效率也较低,但在小脑膜上除外。